{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:07:56Z","timestamp":1761491276056,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T00:00:00Z","timestamp":1630713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.transci.2021.103256","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T14:04:15Z","timestamp":1629209055000},"page":"103256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sero-prevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Norway, winter\/spring 2021"],"prefix":"10.1016","volume":"60","author":[{"given":"Marte","family":"Hvalryg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise Sofie H.","family":"Nissen-Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2021.103256_bib0005","unstructured":"https:\/\/www.fhi.no\/studier\/prevalensundersokelser-korona\/resultat---moba\/ [Accessed June 14th, 2021]."},{"issue":"December","key":"10.1016\/j.transci.2021.103256_bib0010","first-page":"10","article-title":"COVID-19: blood centers rise to the occasion and lead seroprevalence studies","volume":"125","author":"Lieshout-Krikke","year":"2020","journal-title":"Transfusion Today"},{"key":"10.1016\/j.transci.2021.103256_bib0015","doi-asserted-by":"crossref","DOI":"10.17269\/s41997-021-00531-6","article-title":"SARS-CoV-2 seroprevalence among blood donors in Qu\u00e9bec, and analysis of symptoms associated with seropositivity: a nested case-control study","author":"Lewin","year":"2021","journal-title":"Can J Public Health"},{"issue":"Jan. (2)","key":"10.1016\/j.transci.2021.103256_bib0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/cid\/ciaa849","article-title":"Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors","volume":"72","author":"Erikstrup","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"Nov. (1)","key":"10.1016\/j.transci.2021.103256_bib0025","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1038\/s41467-020-19481-7","article-title":"Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands","volume":"11","author":"Slot","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.transci.2021.103256_bib0030","unstructured":"https:\/\/bloddonor.dk\/coronavirus\/ [accessed June 14th, 2021]."},{"issue":"Apr. (2)","key":"10.1016\/j.transci.2021.103256_bib0035","article-title":"The story of an extraordinary year: challenges and opportunities in responding to Covid-19","volume":"60","author":"Nissen-Meyer","year":"2021","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2021.103256_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2020.08.001","article-title":"Clinical characteristics of asymptomatic patients with COVID-19: a nationwide cohort study in South Korea","volume":"99","author":"Jung","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.transci.2021.103256_bib0045","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJMc2001468","article-title":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany","volume":"382","author":"Rothe","year":"2020","journal-title":"N Engl J Med"},{"issue":"Apr. (6538)","key":"10.1016\/j.transci.2021.103256_bib0050","article-title":"Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England","volume":"372","author":"Davies","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.transci.2021.103256_bib0055","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2021-321903","article-title":"Implications of a highly transmissible variant of SARS-CoV-2 for children","author":"Ratmann","year":"2021","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.transci.2021.103256_bib0060","doi-asserted-by":"crossref","first-page":"n616","DOI":"10.1136\/bmj.n616","article-title":"Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools","volume":"372","author":"Ulyte","year":"2021","journal-title":"BMJ"},{"issue":"Jun. (6)","key":"10.1016\/j.transci.2021.103256_bib0065","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/trf.15841","article-title":"SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission","volume":"60","author":"Corman","year":"2020","journal-title":"Transfusion"},{"issue":"40","key":"10.1016\/j.transci.2021.103256_bib0070","doi-asserted-by":"crossref","first-page":"25018","DOI":"10.1073\/pnas.2010540117","article-title":"Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients","volume":"117","author":"Holter","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"year":"2021","series-title":"Seroprevalence of SARS-CoV-2 in the Norwegian population measured in residual sera collected in January 2021. Report 2021","author":"Tunheim","key":"10.1016\/j.transci.2021.103256_bib0075"},{"issue":"Oct. (10)","key":"10.1016\/j.transci.2021.103256_bib0080","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1111\/trf.13205","article-title":"Blood donation and blood donor mortality after adjustment for a healthy donor effect","volume":"55","author":"Ullum","year":"2015","journal-title":"Transfusion"},{"issue":"Mar","key":"10.1016\/j.transci.2021.103256_bib0085","article-title":"Health behavior and lifestyle trends among platelet donors: results from a questionnaire-based survey in Norway","volume":"2021","author":"Mousavi","year":"2021","journal-title":"Biomed Res Int"},{"issue":"Feb. (1)","key":"10.1016\/j.transci.2021.103256_bib0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.transci.2018.12.016","article-title":"Donor health assessment - when is blood donation safe?","volume":"58","author":"Nissen-Meyer","year":"2019","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2021.103256_bib0095","doi-asserted-by":"crossref","DOI":"10.1080\/23744235.2021.1924397","article-title":"Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments","author":"Yong","year":"2021","journal-title":"Infect Dis"},{"key":"10.1016\/j.transci.2021.103256_bib0100","first-page":"1","article-title":"Characteristics of coronavirus disease 19 convalescent plasma donors and donations in the New York metropolitan area","author":"Jain","year":"2021","journal-title":"Transfusion"},{"issue":"Dec. (12)","key":"10.1016\/j.transci.2021.103256_bib0105","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/eji.202048970","article-title":"Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset","volume":"50","author":"Figueiredo-Campos","year":"2020","journal-title":"Eur J Immunol"},{"issue":"Nov. (22)","key":"10.1016\/j.transci.2021.103256_bib0110","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1182\/blood.2020008367","article-title":"Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset","volume":"136","author":"Perreault","year":"2020","journal-title":"Blood"},{"issue":"Sep. (7)","key":"10.1016\/j.transci.2021.103256_bib0115","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10198-014-0625-1","article-title":"Healthy donor effect and satisfaction with health: the role of selection effects related to blood donation behavior","volume":"16","author":"Shehu","year":"2015","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.transci.2021.103256_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2021.04.059","article-title":"Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: the evolution of a pandemic","volume":"107","author":"Sughayer","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"Jun. (22)","key":"10.1016\/j.transci.2021.103256_bib0125","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221002482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221002482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:52:38Z","timestamp":1761468758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050221002482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1473050221002482"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2021.103256","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sero-prevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Norway, winter\/spring 2021","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2021.103256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103256"}}